APMP (formerly APM) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : APMP (formerly APM)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: WTMHouston who wrote (9971)	2/8/1998 11:00:00 AM
From: Richard Haugland	Read Replies (2) of 13456

*1 Stock - 1 Week* MLNM long open Monday Millenium Pharmaceutical announces its earnings later this week. All six analysts rate it a strong buy with one upgrade by Lehman this past month. Earnings are projected to be 77-80 cents a share this past quarter, although most of this is probably from the Monsanto agreement below since the company is in a developmental stage and usually loses money. Its price just hit $20 this week. quicken.excite.com In October 1997, the Company entered into a broad five-year collaboration agreement in genomics research in the agricultural field with Monsanto. As part of the agreement, Monsanto will form a wholly-owned subsidiary and pay Millennium, over the agreement term, $118,000,000 in up front, licensing and technology transfer fees and up to $100,000,000 contingent upon achieving mutually agreed upon research objectives. Monsanto will also fund research activities of its new subsidiary.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next